Clinical Research Support
Clinical Trials Education Office (CTEO)
NCI Investigator Registration
National Cancer Institute (NCI) investigator numbers are required for all attending physicians who will obtain consent from subjects for research related therapy or who will write orders for research related therapy. The NCI investigator registration process is centralized in the Clinical Trials Education Office (CTEO) and the Quality Assurance Office for Clinical Trials (QACT) for DF/HCC investigators.
To confirm the registration status and NCI Investigator Number for a DF/HCC investigator for the current year, please refer to the link below:
NCI Investigator Numbers and Status
Registering a New Investigator:
To register with the NCI a Statement of Investigator Form (FDA Form 1572), Supplemental Investigator Form (IDF), Financial Disclosure Form, and CV must be sent to the CTEO.
This process needs to be completed before the investigator is added to a protocol or is ready to consent participants. Please find the directions and forms below.
Annual Renewal:
The renewal process occurs between the months of June-August of each year. All DF/HCC investigators must renew their registrations at this time regardless of when they last registered.
Renewal consists of submitting a Statement of Investigator Form (FDA Form 1572), Supplemental Investigator Form (IDF), Financial Disclosure Form, and CV to the CTEO. These forms are distributed to the Investigators in a bright red envelope in the beginning of June. Each red packet contains the necessary forms as well as instructions on how to complete the forms and a deadline of form submission.
If you have any questions about NCI Investigator Registration or renewal, please contact the CTEO at 617-582-8480 or cteo@dfci.harvard.edu
Directions and Forms
NCI Investigator Registration Information for DF/HCC Investigators
NCI Investigator Registration Tip Sheet
FDA Form 1572 (Statement of Investigator Form) (BLANK)
FDA Form 1572 (Statement of Investigator Form) (BIDMC)
FDA Form 1572 (Statement of Investigator Form) (BWH/DFCI)
FDA Form 1572 (Statement of Investigator Form) (CHB/DFCI)
FDA Form 1572 (Statment of Investigator Form) (MGH)
Financial Disclosure Form (all institutions)
Supplemental Investigator Data Form (BLANK)
Supplemental Investigator Data Form (BIDMC)
Supplemental Investigator Data Form (BWH/CHB/DFCI)
Supplemental Investigator Data Form (MGH)
Sample Forms: Statement of Investigator, Supplemental Investigator Data and Financial Disclosure (to view comments on a printed version of this form, select the "Document and Comments" field in the "Print What" box)
